Literature DB >> 15833862

Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia.

Linda J Bendall1, Rana Baraz, Julius Juarez, Wei Shen, Kenneth F Bradstock.   

Abstract

The chemokine stromal-derived factor-1alpha (SDF-1alpha) regulates leukemic cell motility and proliferation; however, the importance of these functions in the growth and dissemination of leukemia is unclear. We examined SDF-1alpha-mediated responses of cells from 27 cases of acute lymphoblastic leukemia (ALL). Although cells from the majority of cases showed chemotactic and proliferative responses to SDF-1alpha, a subset of cases did not undergo chemotaxis in response to SDF-1alpha, while still demonstrating dependence on SDF-1alpha for proliferation in stroma-supported cultures. This chemotactic defect was associated with an absence of phosphorylation of p38 mitogen-activated protein kinase (MAPK) induced by SDF-1alpha, and of SDF-1alpha-induced augmentation of beta(1) integrin-mediated adhesion. Signaling through phosphoinositide 3-kinase and MEK was not affected. No correlation was observed between CXCR4 expression and chemotactic function, in vitro migration into bone marrow stromal layers, and engraftment of leukemic cells in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice. This study suggests that signaling through p38 MAPK is required for ALL cell chemotaxis but not for proliferation, and that the loss of a chemotactic response to SDF-1alpha does not impede engraftment in NOD/SCID mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833862     DOI: 10.1158/0008-5472.CAN-04-3402

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

Authors:  Yazan Alsayed; Hai Ngo; Judith Runnels; Xavier Leleu; Ujjal K Singha; Costas M Pitsillides; Joel A Spencer; Teresa Kimlinger; Joanna M Ghobrial; Xiaoying Jia; Ganwei Lu; Michael Timm; Ashok Kumar; Daniel Côté; Israel Veilleux; Karen E Hedin; G David Roodman; Thomas E Witzig; Andrew L Kung; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

2.  Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery.

Authors:  Yan Wang; Ying Xie; David Oupický
Journal:  Curr Pharmacol Rep       Date:  2016-01-04

3.  Homing of cancer cells to the bone.

Authors:  Anjali Mishra; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Cancer Microenviron       Date:  2011-08-09

4.  A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.

Authors:  Reshmi Parameswaran; Markus Müschen; Yong-Mi Kim; John Groffen; Nora Heisterkamp
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

Review 5.  CXCL12/CXCR4 axis in the pathogenesis of acute lymphoblastic leukemia (ALL): a possible therapeutic target.

Authors:  Aparecida de Lourdes Perim; Marla Karine Amarante; Roberta Losi Guembarovski; Carlos Eduardo Coral de Oliveira; Maria Angelica Ehara Watanabe
Journal:  Cell Mol Life Sci       Date:  2015-01-09       Impact factor: 9.261

6.  Sex-based differential regulation of bacterial-induced bone resorption.

Authors:  M S Valerio; D S Basilakos; J E Kirkpatrick; M Chavez; J Hathaway-Schrader; B A Herbert; K L Kirkwood
Journal:  J Periodontal Res       Date:  2016-08-11       Impact factor: 4.419

Review 7.  The intricate role of CXCR4 in cancer.

Authors:  Samit Chatterjee; Babak Behnam Azad; Sridhar Nimmagadda
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

Review 8.  Role of CXCR4 in the progression and therapy of acute leukaemia.

Authors:  Long Su; Zheng Hu; Yong-Guang Yang
Journal:  Cell Prolif       Date:  2021-05-29       Impact factor: 6.831

9.  Inhibition of stromal CXCR4 impairs development of lung metastases.

Authors:  Crescenzo D'Alterio; Antonio Barbieri; Luigi Portella; Giuseppe Palma; Marianeve Polimeno; Anna Riccio; Caterina Ieranò; Renato Franco; Giosuè Scognamiglio; Jane Bryce; Antonio Luciano; Domenica Rea; Claudio Arra; Stefania Scala
Journal:  Cancer Immunol Immunother       Date:  2012-03-08       Impact factor: 6.968

10.  A recombinant protein based on Trypanosoma cruzi P21 enhances phagocytosis.

Authors:  Adele A Rodrigues; Tatiana M Clemente; Marlus A Dos Santos; Fabrício C Machado; Rafael G B Gomes; Heline Hellen T Moreira; Mário C Cruz; Paula C Brígido; Paulo C F Dos Santos; Flávia A Martins; Diana Bahia; Juliana T Maricato; Luiz M R Janini; Eduardo H Reboredo; Renato A Mortara; Claudio V da Silva
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.